SBFM

Conviction 43HealthcareScan · Mon, Aug 10, 2026

Inverted hammer

SBFM$1.21-1.63%

ResistanceSupportVol 14

Vol MA14 1.13M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Sunshine Biopharma Inc.PHARMACEUTICAL PREPARATIONSwww.sunshinebiopharma.com ↗

Price1.21

Change-1.63%

Gap-2.44%

Rel volume0.01×

Avg volume813.07K

Avg $ vol1.03M

SMA 201.52

SMA 501.90

SMA 2001.38

Price vs 50-36.22%

Price vs 200-12.47%

MA stackmixed

50/200 cross—

Supertrenddown · 1.58

RSI (14)33

MACD hist-0.02

MACD cross—

Stoch %K / %D15 / 23

ADX (14)27

+DI / −DI20 / 31

RSI divergence—

MACD divergence—

ATR %+13.78%

ADR %10.67%

52w high2.66

52w low0.2541

From 52w high-54.51%

Above 52w low+376.19%

New 52w highNo

SqueezeOff

Bollinger width69.40%

%B0.21

Donchian pos12.79%

Donchian high1.96

Donchian low1.10

AVWAP (52w high)1.99

vs AVWAP high-39.06%

AVWAP (52w low)1.71

vs AVWAP low-29.27%

OBV trendDown

Chaikin MF (20)-0.33

Today vs 20d0.01×

Avg vol (14d)1.13M

Avg vol (20d)813.07K

Avg $ vol (20d)1.03M

Market cap—

RS 3m (vs SPY)+8.20%

RS 6m (vs SPY)-7.16%

RS line new highNo

Trend template2/8

Technical rank20.7

1 week+3.42%

1 month-42.11%

3 months+15.24%

6 months+0.83%

1 year-13.57%

YTD-5.47%

P/E-1.04

P/B0.29

P/S0.17

P/FCF-1.13

EPS-7.32

Div yield—

ROE-27.77%

ROA-21.39%

Debt/Eq0.10

Current4.22

EV/EBITDA1.95

Gross margin33.76%

Net margin-16.46%

Rev growth4.11%

EPS growth-16.39%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-11.47M

Revenue8.09M

Net income-1.24M

Gross profit2.18M

Free cash flow-5.51M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.12M

Employees50

ListedThu, Aug 9, 2007

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction43 / 100

Pattern quality—

Tech rank20.7 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SBFM

All disclosures →

No recent disclosed trades by Congress in SBFM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SBFM · 1 buy

Insider	Side	Shares	Value	Traded	Filed
NATAN DAVID Director · Common Stock · 2026-04-14	Grant	100K	$0	2026-04-14	2026-04-14

SEC filings

EDGAR filings in SBFM · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.